Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-29Clinical Trial Update: Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)
The BURGER With BACON trial (NCT06283238) evaluating biobanking of upper gastrointestinal tumors to evaluate response has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: Defining Musical Toxicity and Its Effect on Patient Well-being
A Mayo Clinic-sponsored clinical trial titled 'Defining Musical Toxicity and Its Effect on Patient Well-being' has been withdrawn from the r…
-
CLINICAL_TRIALS withdrawal · 2025-04-16Clinical Trial Update: Non-endoscopic EC Screening Program in Northern Iran [NA]
The clinical trial update indicates that the non-endoscopic esophageal cancer screening program in Northern Iran has been suspended.
-
CLINICAL_TRIALS withdrawal · 2024-08-05Clinical Trial Update: Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer [Phase 1, Phase 2]
Phase I/II trial evaluating a cancer lysate vaccine with Montanide ISA-51 VG, entinostat, and nivolumab as adjuvant therapy after chemoradia…
-
CLINICAL_TRIALS withdrawal · 2024-06-13Clinical Trial Update: GI Organ Tracking Via Balloon Applicators [NA]
A clinical trial evaluating GI organ tracking via balloon applicators sponsored by Washington University School of Medicine has been withdra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-02-13Clinical Trial Update: Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery [Phase 3]
A Phase 3 trial evaluating nutritional supplementation to reduce complications in locally advanced esophageal cancer undergoing chemo/radiat…
-
CLINICAL_TRIALS withdrawal · 2021-04-27Clinical Trial Update: Low-dose Aspirin Therapy for Esophageal Cancer [Phase 3]
A Phase 3 clinical trial of low-dose aspirin for esophageal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-14Clinical Trial Update: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment [Phase 2]
A Phase 2 trial evaluating Afatinib in combination with weekly Paclitaxel as second-line therapy for HER-2 positive gastric and gastroesopha…
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery [NA]
The clinical trial evaluating inspiratory muscle training for patients undergoing esophageal surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-13Clinical Trial Update: MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer [Phase 1]
Phase 1 trial of MRI iron oxide imaging for lymph node staging in esophageal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-04Clinical Trial Update: Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial investigating AdcuCD40L (an adenovirus carrying the CD40 ligand gene) for esophageal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-03Clinical Trial Update: Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma [Phase 1]
A Phase 1 safety study evaluating transfer of the CD40 ligand gene (AdcuCD40L) to patients with esophageal cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-21Clinical Trial Update: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. [Phase 1]
A Phase 1 trial of TH-302 (evofosfamide) in combination with preoperative chemoradiotherapy for esophageal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-05Clinical Trial Update: A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer Population [NA]
A pilot study evaluating Acceptance and Commitment Therapy for patients with post-upper GI cancer (esophageal cancer) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers [Phase 2]
Phase 2 trial of personalized therapy for esophagogastric cancer using thymidylate synthase genetic markers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Phase 1, Phase 2]
A phase 1/2 trial of Epirubicin (Pharmorubicin), Carboplatin (Paraplatin) and Capecitabine (Xeloda) for unresectable locally advanced or met…
-
CLINICAL_TRIALS withdrawal · 2015-11-20Clinical Trial Update: Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel liposome plus cisplatin as first-line therapy for metastatic esophageal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus [Phase 2]
Clinical trial update shows a Phase 2 evaluation of a new covered metal stent for malignant esophageal lesions has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-09Clinical Trial Update: Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer [Phase 3]
Phase 3 trial evaluating aprotinin to reduce transfusion requirements in patients undergoing lung or esophageal cancer surgery has been term…
-
CLINICAL_TRIALS withdrawal · 2014-08-01Clinical Trial Update: KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer [Phase 1]
This clinical trial update reports the withdrawal of a Phase 1 study evaluating KD019 in combination with Trastuzumab for esophageal, gastro…
-
CLINICAL_TRIALS withdrawal · 2014-07-28Clinical Trial Update: Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation
This clinical trial in esophageal cancer evaluating cardiac biomarkers during chemotherapy and radiation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-04Clinical Trial Update: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light [Phase 2]
A Phase 2 clinical trial evaluating a sunscreen to prevent porfimer sodium–induced phototoxicity to visible light has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Comparison of Standard of Care or Treatment on Protocol [NA]
A terminated clinical trial (NCT01010334) comparing standard of care versus a protocol treatment. The study covers several cancers, includin…
-
CLINICAL_TRIALS withdrawal · 2012-09-14Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer [Phase 1]
A Phase 1 trial evaluating radiolabeled monoclonal antibody therapy for gastrointestinal cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-02Clinical Trial Update: Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer [NA]
This clinical trial investigating pre-treatment with HPPH photodynamic therapy before chemoradiation for non-operable obstructive esophageal…